Gilead Sciences
$144.74Change from previous close: −1.87%Absolute change: −$2.76
At a glance
- Revenue growth
- +2.40%
- 2025 vs 2024
- Net income growth
- +1,672.92%
- 2025 vs 2024
- Net margin
- 28.9%
- 2024: 1.7%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 49,362 | 56,278 | 59,023 | 58,533 | 55,721 | 56,434 | 58,995 | 54,525 | 53,579 | 56,292 | 62,125 | 62,373 |
| Current assets | 13,945 | 18,641 | 18,342 | 17,874 | 14,718 | 16,901 | 19,173 | 14,779 | 12,317 | 14,041 | 16,085 | 15,980 |
| Cash and equivalents | 3,179 | 7,628 | 7,564 | 7,330 | 5,144 | 7,926 | 9,991 | 5,037 | 2,772 | 4,718 | 6,085 | 5,705 |
| Short-term investments | 1,703 | 2,189 | 2,049 | 1,160 | 914 | 785 | 1,577 | 1,660 | 1,009 | 806 | 2,265 | 2,269 |
| Receivables | 5,055 | 4,741 | 4,913 | 5,095 | 4,781 | 4,388 | 4,420 | 4,587 | 4,663 | 4,669 | 4,660 | 4,790 |
| Inventory | 1,953 | 1,914 | 1,774 | 1,785 | 1,825 | 1,759 | 1,710 | 1,869 | 2,026 | 1,853 | 1,787 | 1,663 |
| Net property, plant and equipment | 5,833 | 5,638 | 6,138 | 5,500 | 5,459 | 5,421 | 5,929 | 5,391 | 5,346 | 5,321 | 5,898 | 5,572 |
| Goodwill | 8,314 | 8,314 | 8,314 | 8,314 | 8,314 | 8,314 | 8,314 | 8,314 | 8,314 | 8,314 | 8,314 | 8,314 |
| Other intangible assets | 14,032 | 16,382 | 16,978 | 17,970 | 18,566 | 19,355 | 19,948 | 20,546 | 22,832 | 23,428 | 26,454 | 27,152 |
| Long-term investments | 726 | 1,670 | 3,753 | 2,778 | 2,640 | 684 | 713 | 730 | 706 | 1,144 | 1,819 | 1,737 |
| Current liabilities | 11,020 | 9,476 | 11,813 | 12,298 | 11,189 | 12,344 | 12,004 | 11,725 | 10,781 | 13,015 | 11,280 | 11,945 |
| Accounts payable | 674 | 645 | 715 | 808 | 582 | 737 | 833 | 903 | 537 | 622 | 550 | 586 |
| Long-term debt | 23,832 | 20,861 | 22,129 | 22,135 | 22,140 | 22,146 | 24,896 | 21,437 | 21,540 | 21,527 | 23,189 | 23,189 |
| Total debt | 26,246 | 22,174 | 24,936 | 24,941 | 24,946 | — | — | — | — | — | — | — |
| Total liabilities | 37,617 | 32,847 | 36,405 | 37,077 | 36,131 | 37,356 | 39,749 | 36,134 | 35,382 | 38,837 | 39,376 | 40,131 |
| Total equity (incl. minority) | 11,745 | 23,431 | 22,618 | 21,456 | 19,590 | 19,078 | 19,246 | 18,391 | 18,197 | 17,455 | 22,749 | 22,242 |
| Retained earnings | 2,200 | 14,131 | 13,730 | 12,825 | 11,325 | 10,931 | 11,497 | 11,073 | 11,165 | 10,656 | 16,304 | 16,002 |
| Minority interest | -84.0 | -84.0 | -84.0 | -84.0 | -84.0 | -84.0 | -84.0 | -84.0 | -84.0 | -84.0 | -84.0 | -72.0 |
